Crispr Therapeutics Ag (CRSP)

Finanzdaten der Crispr Therapeutics Ag-Aktie (CRSP)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-09-30	2026-06-30	2026-03-31	2025-12-31	2025-09-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	24.44%12.67	10.18	1.46	0.86	0.89
	11.98%142.71	127.45	131.71	155.63	132.95
Research and Development	7.05%71.89	67.15	68.57	83.53	58.90
Operating Income/Loss	10.89%-130.05	-117.27	-130.25	-154.76	-132.06
Nonoperating Income/Loss	31.00%18.68	27.08	8.16	24.77	26.24
Income/Loss From Continuing Operations Before Tax	23.47%-111.36	-90.19	-122.09	-130.00	-105.82
Income Tax Expense/Benefit	92.29%0.07	0.96	0.84	0.61	0.62
	22.25%-111.44	-91.15	-122.93	-130.61	-106.44
Attributable To Parent	22.25%-111.44	-91.15	-122.93	-130.61	-106.44
Basic Average Shares	0.24%96.74	96.51	96.05	1.80	91.31
Diluted Average Shares	0.24%96.74	96.51	96.05	1.80	91.31
Basic Earnings Per Share	22.34%-1.15	-0.94	-1.28	-1.35	-1.17
Diluted Earnings Per Share	22.34%-1.15	-0.94	-1.28	-1.35	-1.17